| Product Code: ETC12750901 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
Latvia`s nimodipine import market in 2024 saw significant growth, with top exporting countries including Ukraine, Netherlands, India, China, and Germany. The high Herfindahl-Hirschman Index (HHI) indicates concentrated market control. The compound annual growth rate (CAGR) from 2020 to 2024 was an impressive 50.07%, with a notable growth rate of 34.18% from 2023 to 2024. This data suggests a robust and dynamic market for nimodipine imports in Latvia, driven by strong partnerships with key exporting countries.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Nimodipine Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Nimodipine Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Nimodipine Market - Industry Life Cycle |
3.4 Latvia Nimodipine Market - Porter's Five Forces |
3.5 Latvia Nimodipine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Latvia Nimodipine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Latvia Nimodipine Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.8 Latvia Nimodipine Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Latvia Nimodipine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders in Latvia |
4.2.2 Growing awareness about the benefits of nimodipine in treating subarachnoid hemorrhage |
4.2.3 Technological advancements in drug delivery systems |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approvals in Latvia |
4.3.2 High cost associated with nimodipine treatment |
4.3.3 Limited availability of nimodipine in rural areas |
5 Latvia Nimodipine Market Trends |
6 Latvia Nimodipine Market, By Types |
6.1 Latvia Nimodipine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Latvia Nimodipine Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Latvia Nimodipine Market Revenues & Volume, By Immediate-Release, 2021 - 2031F |
6.1.4 Latvia Nimodipine Market Revenues & Volume, By Extended-Release, 2021 - 2031F |
6.1.5 Latvia Nimodipine Market Revenues & Volume, By Combination Drugs, 2021 - 2031F |
6.2 Latvia Nimodipine Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Latvia Nimodipine Market Revenues & Volume, By Subarachnoid Hemorrhage, 2021 - 2031F |
6.2.3 Latvia Nimodipine Market Revenues & Volume, By Stroke Prevention, 2021 - 2031F |
6.2.4 Latvia Nimodipine Market Revenues & Volume, By Neurological Disorders, 2021 - 2031F |
6.3 Latvia Nimodipine Market, By Dosage Form |
6.3.1 Overview and Analysis |
6.3.2 Latvia Nimodipine Market Revenues & Volume, By Capsules, 2021 - 2031F |
6.3.3 Latvia Nimodipine Market Revenues & Volume, By Tablets, 2021 - 2031F |
6.3.4 Latvia Nimodipine Market Revenues & Volume, By Injection, 2021 - 2031F |
6.4 Latvia Nimodipine Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Latvia Nimodipine Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Latvia Nimodipine Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4.4 Latvia Nimodipine Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
7 Latvia Nimodipine Market Import-Export Trade Statistics |
7.1 Latvia Nimodipine Market Export to Major Countries |
7.2 Latvia Nimodipine Market Imports from Major Countries |
8 Latvia Nimodipine Market Key Performance Indicators |
8.1 Patient adherence rate to nimodipine treatment |
8.2 Number of clinical trials conducted on nimodipine in Latvia |
8.3 Percentage increase in prescriptions of nimodipine by healthcare providers |
9 Latvia Nimodipine Market - Opportunity Assessment |
9.1 Latvia Nimodipine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Latvia Nimodipine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Latvia Nimodipine Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.4 Latvia Nimodipine Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Latvia Nimodipine Market - Competitive Landscape |
10.1 Latvia Nimodipine Market Revenue Share, By Companies, 2024 |
10.2 Latvia Nimodipine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here